CRYSTAL ROGER

CIK 00016566332 companiesNEW YORK, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001656633

Recent Transactions

50 trades

Award
Definium Therapeutics, Inc.$DFTX
Stock Option (Right to Buy)
2026-06-11+19,188→ 19,188 total
Award
Definium Therapeutics, Inc.$DFTX
Common Shares
2026-06-11+4,666→ 24,289 total
Award
Definium Therapeutics, Inc.$DFTX
Stock Option (Right to Buy)
2025-06-12+75,187→ 75,187 total
Award
Definium Therapeutics, Inc.$DFTX
Stock Option (Right to Buy)
2024-06-10+16,506→ 16,506 total
Award
Definium Therapeutics, Inc.$DFTX
Common Shares
2023-06-21+13,671→ 19,623 total
Award
Definium Therapeutics, Inc.$DFTX
Stock Option (Right to Buy)
2023-06-21+19,203→ 27,267 total
Disposition to Issuer
OPIANT PHARMACEUTICALS, INC.
Option
2023-03-02−25,000→ 0 total
Disposition to Issuer
OPIANT PHARMACEUTICALS, INC.
Common Stock
2023-03-02$20.00/sh−6,667→ 0 total
Disposition to Issuer
OPIANT PHARMACEUTICALS, INC.
Option
2023-03-02−150,000→ 0 total
Disposition to Issuer
OPIANT PHARMACEUTICALS, INC.
Option
2023-03-02−25,000→ 0 total
Disposition to Issuer
OPIANT PHARMACEUTICALS, INC.
Stock Option (right to buy)
2023-03-02−31,250→ 0 total
Disposition to Issuer
OPIANT PHARMACEUTICALS, INC.
Common Stock
2023-03-02$20.00/sh−37,438→ 37,901 total
Disposition to Issuer
OPIANT PHARMACEUTICALS, INC.
Common Stock
2023-03-02$20.00/sh−37,901→ 0 total
Disposition to Issuer
OPIANT PHARMACEUTICALS, INC.
Common Stock par value $0.001
2023-03-02$20.00/sh−5,100→ 0 total
Award
OPIANT PHARMACEUTICALS, INC.
Common Stock
2023-03-02+6,667→ 6,667 total
Disposition to Issuer
OPIANT PHARMACEUTICALS, INC.
Option
2023-03-02−375,000→ 0 total
Disposition to Issuer
OPIANT PHARMACEUTICALS, INC.
Stock Option (right to buy)
2023-03-02−13,200→ 0 total
Disposition to Issuer
OPIANT PHARMACEUTICALS, INC.
Common Stock
2023-03-02−27,250→ 0 total
Sale
OPIANT PHARMACEUTICALS, INC.
Common Stock
2023-01-27$20.26/sh−1,358→ 75,339 total
Sale
OPIANT PHARMACEUTICALS, INC.
Common Stock
2023-01-09$20.20/sh−1,183→ 76,697 total
Sale
OPIANT PHARMACEUTICALS, INC.
Common Stock
2023-01-05$20.20/sh−5,029→ 77,880 total
Award
Definium Therapeutics, Inc.$DFTX
Director's Deferred Share Units
2022-08-11+503,773→ 503,773 total
Award
Definium Therapeutics, Inc.$DFTX
Common Shares
2022-08-11+89,286→ 89,286 total
Award
Definium Therapeutics, Inc.$DFTX
Stock Option (Right to Buy)
2022-08-11+120,968→ 120,968 total
Sale
OPIANT PHARMACEUTICALS, INC.
Common Stock
2022-07-14$11.11/sh−2,246→ 82,909 total
Award
OPIANT PHARMACEUTICALS, INC.
Common Stock
2022-06-27+6,667→ 85,155 total
Sale
OPIANT PHARMACEUTICALS, INC.
Common Stock
2022-01-27$26.15/sh−1,995→ 78,488 total
Sale
OPIANT PHARMACEUTICALS, INC.
Common Stock
2022-01-10$30.49/sh−1,058→ 80,483 total
Award
OPIANT PHARMACEUTICALS, INC.
Common Stock
2022-01-04+40,000→ 81,541 total
Purchase
OPIANT PHARMACEUTICALS, INC.
Common Stock par value $0.001
2021-09-16$23.44/sh+100→ 5,100 total
Award
OPIANT PHARMACEUTICALS, INC.
Stock Option (right to buy)
2021-01-26+31,250→ 31,250 total
Award
OPIANT PHARMACEUTICALS, INC.
Common Stock
2021-01-26+15,650→ 41,541 total
Award
OPIANT PHARMACEUTICALS, INC.
Common Stock
2021-01-26+3,766→ 25,891 total
Award
OPIANT PHARMACEUTICALS, INC.
Common Stock
2020-01-07+13,650→ 22,125 total
Award
OPIANT PHARMACEUTICALS, INC.
Common Stock
2020-01-07+27,250→ 27,250 total
Sale
OPIANT PHARMACEUTICALS, INC.
Common Stock
2019-04-08$12.10/sh−12,772→ 8,475 total
Exercise/Conversion
OPIANT PHARMACEUTICALS, INC.
Option
2019-04-05$7.25/sh−21,472→ 375,000 total
Sale
OPIANT PHARMACEUTICALS, INC.
Common Stock
2019-04-05$11.98/sh−16,001→ 21,247 total
Exercise/Conversion
OPIANT PHARMACEUTICALS, INC.
Common Stock
2019-04-05$7.25/sh+21,472→ 37,248 total
Exercise/Conversion
OPIANT PHARMACEUTICALS, INC.
Option
2019-04-04$7.25/sh−22,557→ 396,472 total
Sale
OPIANT PHARMACEUTICALS, INC.
Common Stock
2019-04-04$11.93/sh−16,836→ 15,776 total
Exercise/Conversion
OPIANT PHARMACEUTICALS, INC.
Common Stock
2019-04-04$7.25/sh+22,557→ 32,612 total
Exercise/Conversion
OPIANT PHARMACEUTICALS, INC.
Common Stock
2019-04-03$7.25/sh+5,149→ 14,446 total
Sale
OPIANT PHARMACEUTICALS, INC.
Common Stock
2019-04-03$12.24/sh−3,791→ 10,055 total
Exercise/Conversion
OPIANT PHARMACEUTICALS, INC.
Option
2019-04-03$7.25/sh−5,149→ 419,029 total
Exercise/Conversion
OPIANT PHARMACEUTICALS, INC.
Common Stock
2019-04-02$7.25/sh+822→ 9,297 total
Exercise/Conversion
OPIANT PHARMACEUTICALS, INC.
Option
2019-04-02$7.25/sh−822→ 424,178 total
Sale
OPIANT PHARMACEUTICALS, INC.
Common Stock
2019-04-02$12.48/sh−600→ 13,846 total
Award
OPIANT PHARMACEUTICALS, INC.
Stock Option (right to buy)
2019-01-15+13,200→ 13,200 total
Sale
OPIANT PHARMACEUTICALS, INC.
Common Stock
2019-01-08$13.27/sh−11,407→ 8,475 total

Companies

Recent Filings

Address

C/O DEFINIUM THERAPEUTICS, INC. ONE WORLD TRADE CENTER, SUITE 8500

NEW YORK, NY, 10007

View on SEC.gov